BR112014010107A2 - refeição destinada ao consumo humano, uso da refeição e método para a prevenção ou tratamento de doença cardiovascular, diabetes o tipo 2 e obesidade; e para o controle de peso e perda de peso - Google Patents

refeição destinada ao consumo humano, uso da refeição e método para a prevenção ou tratamento de doença cardiovascular, diabetes o tipo 2 e obesidade; e para o controle de peso e perda de peso

Info

Publication number
BR112014010107A2
BR112014010107A2 BR112014010107A BR112014010107A BR112014010107A2 BR 112014010107 A2 BR112014010107 A2 BR 112014010107A2 BR 112014010107 A BR112014010107 A BR 112014010107A BR 112014010107 A BR112014010107 A BR 112014010107A BR 112014010107 A2 BR112014010107 A2 BR 112014010107A2
Authority
BR
Brazil
Prior art keywords
meal
obesity
diabetes
prevention
treatment
Prior art date
Application number
BR112014010107A
Other languages
English (en)
Portuguese (pt)
Inventor
Frances Jennifer Bligh Heather
John Hunter Karl
Macau Lay Katrina
Ian Fowler Mark
John Berry Mark
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of BR112014010107A2 publication Critical patent/BR112014010107A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112014010107A 2011-11-29 2012-11-28 refeição destinada ao consumo humano, uso da refeição e método para a prevenção ou tratamento de doença cardiovascular, diabetes o tipo 2 e obesidade; e para o controle de peso e perda de peso BR112014010107A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11191182 2011-11-29
PCT/EP2012/073846 WO2013079536A1 (en) 2011-11-29 2012-11-28 A meal intended for human consumption

Publications (1)

Publication Number Publication Date
BR112014010107A2 true BR112014010107A2 (pt) 2017-04-25

Family

ID=47226200

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014010107A BR112014010107A2 (pt) 2011-11-29 2012-11-28 refeição destinada ao consumo humano, uso da refeição e método para a prevenção ou tratamento de doença cardiovascular, diabetes o tipo 2 e obesidade; e para o controle de peso e perda de peso

Country Status (10)

Country Link
US (2) US9386792B2 (https=)
EP (1) EP2785201A1 (https=)
CN (1) CN104039170A (https=)
AU (1) AU2012343964B2 (https=)
BR (1) BR112014010107A2 (https=)
CA (1) CA2852032A1 (https=)
EA (1) EA027364B1 (https=)
IN (1) IN2014MN00932A (https=)
WO (1) WO2013079536A1 (https=)
ZA (1) ZA201402770B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015182955A (ja) * 2014-03-20 2015-10-22 学校法人中部大学 Ｇｌｐ−１分泌促進剤
CN111096972B (zh) * 2020-02-25 2023-07-14 成都医学院 一种预防和/或治疗阿尔茨海默症的药物组合物
CA3177611A1 (en) * 2020-06-09 2021-12-16 H.J. Heinz Company Brands Llc Modular meal system and method of making a modular meal system
USD1057556S1 (en) 2021-10-29 2025-01-14 H. J. Heinz Company Brands Llc Tray
CN115645431B (zh) * 2022-12-12 2023-03-21 汤臣倍健股份有限公司 一种组合物及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039989A (en) 1995-06-06 2000-03-21 Campbell Soup Company Prepackaged therapeutic meal for treatment of diet-responsive conditions
WO1996039053A2 (en) 1995-06-06 1996-12-12 Campbell Soup Company Mineral supplements for dietetic food
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
US20020054924A1 (en) * 2000-04-13 2002-05-09 Leahy Margaret M. Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor
WO2002011562A2 (en) 2000-08-08 2002-02-14 Advanced Functional Foods International, Inc. Nutritional supplement for the management of weight
US6808727B2 (en) 2001-07-20 2004-10-26 Emanuel S. Kemeny Meal-equivalent food bar
US7030092B1 (en) * 2001-08-24 2006-04-18 Small Giant L.L.C. Ultra-high fiber supplement and method of reducing weight cardiovascular risks and ingested toxins.
US6585998B2 (en) * 2001-11-13 2003-07-01 Rudolph Cartwright Nutraceutical composition
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US7767245B2 (en) 2003-09-12 2010-08-03 Ray And Terry's Health Products, Inc. Meal replacement beverage
CA2577984C (en) 2004-08-25 2012-01-24 Regents Of The University Of Minnesota Compositions and methods to lower glycohemoglobin levels
US20060188590A1 (en) * 2005-01-05 2006-08-24 Mitsunori Ono Compositions for treating diabetes or obesity
US7977319B1 (en) * 2006-04-03 2011-07-12 Scott David Levine Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins
US20080305096A1 (en) 2007-06-07 2008-12-11 Unicity International, Inc. Method and composition for providing controlled delivery of biologically active substances
US20100093678A1 (en) * 2008-10-10 2010-04-15 The University Of Georgia Research Foundation, Inc Compositions and methods of the treatment of obesity and osteoporosis
WO2010105253A2 (en) * 2009-03-13 2010-09-16 The Salk Institute For Biological Studies Methods and compositions for treating complications of diabetes and vascular diseases using flavones
EP2316271A1 (fr) 2009-10-26 2011-05-04 ET & DS Company Ltd Substitut de repas sous forme d'un aliment à cuire de type pain et d'un aliment d'accompagnement de type pâte à tartiner.
WO2011060307A2 (en) 2009-11-13 2011-05-19 Jingxuan Kang Food products having multiple health benefits
EP2509434A4 (en) 2009-12-07 2015-06-24 Leonardo Carella CALORIE ARMS, PROPERTY-FRIENDLY MOLDED FORMING AND MANUFACTURING METHOD
BR112012030117A2 (pt) * 2010-05-28 2017-05-16 Unilever Nv pluralidade de composições, uso da mesma e método para a prevenção ou tratamento de doença cardiovascular, diabetes do tipo 2, inflamação, diarréia e saúde óssea
MX2013003985A (es) * 2010-10-14 2014-05-01 Asha Nutrition Sciences Inc Formulaciones nutritivas optimizadas, metodos para la seleccion de dietas adaptadas a partir de las mismas, y metodos para utilizar las mismas.
CN102077949B (zh) 2011-01-27 2013-01-16 北京康比特体育科技股份有限公司 一种减肥代餐营养棒及其制备方法
CN102224933B (zh) 2011-05-13 2013-07-17 烟台新时代健康产业有限公司 辅助调节血脂的组合物、保健食品及其应用
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions
JP2015505320A (ja) * 2012-01-16 2015-02-19 グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー２、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｎｏ．２ Ｌｉｍｉｔｅｄ 糖尿病及び／又は肥満の治療のための組成物及び方法
US9132117B2 (en) * 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose

Also Published As

Publication number Publication date
EA201491050A1 (ru) 2014-09-30
AU2012343964A1 (en) 2014-04-24
IN2014MN00932A (https=) 2015-04-17
US9386792B2 (en) 2016-07-12
AU2012343964B2 (en) 2015-02-05
US20160286841A1 (en) 2016-10-06
US20140308392A1 (en) 2014-10-16
CA2852032A1 (en) 2013-06-06
EA027364B1 (ru) 2017-07-31
ZA201402770B (en) 2015-11-25
WO2013079536A1 (en) 2013-06-06
CN104039170A (zh) 2014-09-10
EP2785201A1 (en) 2014-10-08
US9750272B2 (en) 2017-09-05

Similar Documents

Publication Publication Date Title
CL2013002210A1 (es) Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano.
BR112013022927A2 (pt) composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
IL244668A0 (en) Compositions and formulations for prevention and treatment of diabetes and obesity, and methods of production and use thereof in glucose and caloric control
BR112015003332A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
BR112015003398A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
BRPI0812524A2 (pt) Amidohidrolases para a preparação de gêneros alimentícios ou estimulantes
BRPI1011752A2 (pt) "montagem de completação para estimular, segmentar e controlar poços de erd"
CL2014001994A1 (es) Polipeptido mimético de apelina sintéticos para el tratamiento e insuficiencia cardiaca; composicion farmacéutica que comprende dicho polipeptido.
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
CL2014000801A1 (es) Variante de factor 21 de crecimiento de fibroblasto humano (fgf21); composicion farmaceutica que lo comprende; y su uso para tratar diabetes tipo 2, obesidad, dislipidemia, sindrome metabolico o cualquier combinacion de los mismos.
CL2013001410A1 (es) Variante polipeptidica de fgf21; multimero que la comprende; composicion farmaceutica que la comprende; y su uso para tratar uno o mas trastornos asociados a fgf21.
HUE061596T2 (hu) Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben
BRPI0814825A2 (pt) Composto, processo para a preparação do composto, composição farmacêutica que o compreende, seu uso e métodos para o tratamento ou profilaxia de diabetes, obesidade, distúrbios de alimentação ou dislipimedia e diabetes do tipo ii
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
BR112013001571A2 (pt) composto, composição farmacêutica, uso e método de prevenção ou tratamento de uma condição associada com a função do receptor gpr40
PT2796457T (pt) Genz 112638 para o tratamento de doença de gaucher ou de fabry em terapia de associação
BR112014010177A2 (pt) composto, composição farmacêutica, uso do composto, e, método para a profilaxia ou tratamento de um estado ou uma condição de doença
BRPI0918139A2 (pt) composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
DK2603596T3 (da) Sammensætninger, som omfatter et polypeptid med cellulolyseforbedrende aktivitet og en væske, og anvendelser deraf
BRPI0924189A2 (pt) dispositivo para o controle da passagem de pessoas
BR112013015855A2 (pt) composto, uso de um composto, métodos de prevenção, tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica.
CL2008000198A1 (es) Compuestos derivados de azacicloalcanos, inhibidores de estearoil-coenzima a delta-9; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como diabetes tipo 2, trastorno de lipidos, obesidad y aterosclerosis.
PL2442814T3 (pl) Bifidobacteria do leczenia cukrzycy i pokrewnych chorób
BRPI0815836A2 (pt) Construção de antígeno-vetor de fluorocarboneto, vetor de fluorocarboneto, composição farmacêutica, uso da construção, e, métodos de tratamento ou imunização, para estimular uma resposta imune, e para preparar uma resposta farmacêutica profilática ou terapêutica.
CL2012000487A1 (es) Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales.

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: A23L 33/21 (2016.01)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B350 Update of information on the portal [chapter 15.35 patent gazette]